• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A study of the haematologic spectrum of myelodysplastic syndrome.

作者信息

Kini J, Khadilkar U N, Dayal J P

机构信息

Department of Pathology, Kottayam Medical College, Kottayam.

出版信息

Indian J Pathol Microbiol. 2001 Jan;44(1):9-12.

PMID:12561987
Abstract

In 31 patients of myelodysplastic syndrome, RAEB-t was the commonest subtype (29%), and RARS, the lease common (6.4%); 19.4% were characterised as the unclassifiable (UC) group. Pallor was the dominant sign (90.3%). Low haemoglobin in RA & RARS (p<0.05), thrombocytopenia in RAEB-t (p<0.01) and high leuco/monocyte counts in CMML (p<0.001) were observed. Neutropenia occurred most frequently in RAEB & RAEB-t and circulating blasts in all cases of RAEB-t and CMML. Bicytopenia was the commonest finding (58.1%) and pancytopenia the least (16.1%). 84% of marrows were hypercellular and trilineage dysplasia was seen in 68% of patients. Megaloblastoid dyserythropoiesis was the predominant feature in all cases, dysgranulopoiesis in all cases of RAEB, RAEB-t and CMML, and micromegokaryocytes in all cases of RARS, RAEB & CMML were seen. RAEB-t and RAEB (33.3% each) were the predominant groups which progressed to leukemia, FAB AML-M2, being the commonest type (60%).

摘要

相似文献

1
A study of the haematologic spectrum of myelodysplastic syndrome.
Indian J Pathol Microbiol. 2001 Jan;44(1):9-12.
2
Clinical, hematological and histomorphological profile of myelodysplastic syndrome.骨髓增生异常综合征的临床、血液学及组织形态学特征
J Assoc Physicians India. 2001 Apr;49:430-4.
3
[Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].226例骨髓增生异常综合征患者血液治疗支持的回顾性分析
Sangre (Barc). 1994 Apr;39(2):117-20.
4
Transformation of myelodysplastic syndromes into acute myeloid leukemias.骨髓增生异常综合征向急性髓系白血病的转化。
Chin Med J (Engl). 2004 Jul;117(7):963-7.
5
Primary myelodysplastic syndrome: clinical spectrum of 53 cases.原发性骨髓增生异常综合征:53例临床谱
J Pak Med Assoc. 1998 Mar;48(3):69-73.
6
[Hematological study in 27 patients with myelodysplastic syndrome (MDS)].27例骨髓增生异常综合征(MDS)患者的血液学研究
Rinsho Byori. 1993 Jan;41(1):107-11.
7
[The International Prognostic Scoring System for primary myelodysplastic syndrome].[原发性骨髓增生异常综合征国际预后评分系统]
Sb Lek. 2002;103(3):333-8.
8
[Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].骨髓增生异常综合征(MDS)的病理生理学研究——与白血病转化相关的巨核细胞生成异常模式
Rinsho Ketsueki. 1989 Oct;30(10):1788-99.
9
[Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].29例伴20号染色体长臂缺失的骨髓增生异常综合征的临床及细胞遗传学特征
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):171-2.
10
[Myelodysplastic syndrome--classification, prognosis and therapy].[骨髓增生异常综合征——分类、预后及治疗]
Cas Lek Cesk. 2002 Sep 22;141 Suppl:33-7.

引用本文的文献

1
Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.阿柔比星与小剂量阿糖胞苷联合粒细胞集落刺激因子治疗复发或难治性急性髓系白血病及骨髓增生异常综合征:112例中国患者的多中心研究
Int J Hematol. 2005 Jul;82(1):48-54. doi: 10.1532/IJH97.A10424.